Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Lew

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
The Journal of Investigative Dermatology|May 19, 2010
Early death from clinical stage I melanomaA J Sober, C L Day, T B Fitzpatrick, et al.
The Journal of Investigative Dermatology|May 19, 2010
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patientsA J Sober, C L Day, T B Fitzpatrick, et al.
American Journal of Public Health|April 1, 1996
Cutaneous melanoma mortality among the socioeconomically disadvantaged in MassachusettsA C Geller, D R Miller, R A Lew, et al.
Journal of Spinal Disorders|May 6, 1999
Factors affecting lumbar spinal fusionR K Snider, N K Krumwiede, L J Snider, et al.
Journal of the American Academy of Dermatology|August 1, 1990
Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on societyV A Albert, H K Koh, A C Geller, et al.
British Journal of Pharmacology|March 1, 1995
Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitorS E Telford, A I Smith, R A Lew, et al.
Journal of General Internal Medicine|March 1, 1992
Use of health services before the diagnosis of melanoma: implications for early detection and screeningA C Geller, H K Koh, D R Miller, et al.
CA: a Cancer Journal for Clinicians|March 1, 1982
Cutaneous malignant melanoma: prognostic guidelines for physicians and patientsC L Day, M C Mihm, R A Lew, et al.
The Journal of Investigative Dermatology|June 1, 1983
Early death from clinical stage I melanomaA J Sober, C L Day, T B Fitzpatrick, et al.
British Journal of Pharmacology|July 1, 1996
Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivoR A Lew, F Tomoda, R G Evans, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
The Journal of Investigative Dermatology|May 19, 2010
Early death from clinical stage I melanomaA J Sober, C L Day, T B Fitzpatrick, et al.
The Journal of Investigative Dermatology|May 19, 2010
Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patientsA J Sober, C L Day, T B Fitzpatrick, et al.
American Journal of Public Health|April 1, 1996
Cutaneous melanoma mortality among the socioeconomically disadvantaged in MassachusettsA C Geller, D R Miller, R A Lew, et al.
Journal of Spinal Disorders|May 6, 1999
Factors affecting lumbar spinal fusionR K Snider, N K Krumwiede, L J Snider, et al.
Journal of the American Academy of Dermatology|August 1, 1990
Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on societyV A Albert, H K Koh, A C Geller, et al.
British Journal of Pharmacology|March 1, 1995
Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitorS E Telford, A I Smith, R A Lew, et al.
Journal of General Internal Medicine|March 1, 1992
Use of health services before the diagnosis of melanoma: implications for early detection and screeningA C Geller, H K Koh, D R Miller, et al.
CA: a Cancer Journal for Clinicians|March 1, 1982
Cutaneous malignant melanoma: prognostic guidelines for physicians and patientsC L Day, M C Mihm, R A Lew, et al.
The Journal of Investigative Dermatology|June 1, 1983
Early death from clinical stage I melanomaA J Sober, C L Day, T B Fitzpatrick, et al.
British Journal of Pharmacology|July 1, 1996
Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivoR A Lew, F Tomoda, R G Evans, et al.
Pageof 17